Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission

Clinical Infectious Diseases

Volumn 56, Issue 1, 2013, Pages 131-139

  Hudgens, Michael G ^a   Taha, Taha E ^b   Omer, Saad B ^c   Jamieson, Denise J ^d   Lee, Hana ^a   Mofenson, Lynne M ^e   Chasela, Charles ^f   Kourtis, Athena P ^d   Kumwenda, Newton ^b   Ruff, Andrea ^b   Bedri, Abubaker ^g   Jackson, J Brooks ^b   Musoke, Philippa ^h   Bollinger, Robert C ^b   Gupte, Nikhil ^b   Thigpen, Michael C ^d   Taylor, Allan ^d   Van Der Horst, Charles ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^f UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^g ADDIS ABABA UNIVERSITY   (Ethiopia)

^h MAKERERE UNIVERSITY   (Uganda)

Author keywords

breast milk; HIV; nevirapine

Indexed keywords

LAMIVUDINE PLUS ZIDOVUDINE; NEVIRAPINE; ZIDOVUDINE;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BIRTH WEIGHT; BREAST MILK; CD4 LYMPHOCYTE COUNT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE DRUG DOSE; VIRUS TRANSMISSION;

EID: 84871227063     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis808     Document Type: Article

References (22)

1. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic, 2010. Available at: http://www.unaids.org/globalreport/documents/20101123- GlobalReport-full-en.pdf. Accessed 19 June 2012.
2. Thior I, Lockman S, Smeaton LM, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana. A randomized trial: the Mashi study. JAMA 2006; 296:794-805.
3. World Health Organization Collaborative Study Team on the Role of Breastfeeding on the Prevention of Infant Mortality. Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. Lancet 2000; 355:451-5.
4. Fawzy A, Arpadi S, Kankasa C, et al. Early weaning increases diarrheal morbidity and mortality among uninfected children born to HIV-infected mothers in Zambia. J Infect Dis 2011; 203:1222-30.
5. Creek TL, Kim A, Lu L, et al. Hospitalization and mortality among primarily non-breastfed children during a large outbreak of diarrhea and malnutrition in Botswana, 2006. J Acquir Immune Defic Syndr 2010; 53:14-9.
6. Kafulafula G, Hoover DR, Taha TE, et al. Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-infected women in Malawi. J Acquir Immune Defic Syndr 2010; 53:6-13.
7. World Health Organization. HIV and infant feeding: revised principles and recommendations. Rapid advice. Geneva, Switzerland: WHO. 2009. Available at: http://whqlibdoc.who.int/publications/2009/97892 41598873-eng.pdf. Accessed 14 February 2012.
8. Bedri A, Gudetta B, Isehak A, et al. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet 2008; 372:300-13.
9. Chasela CS, Hudgens MG, Jamieson DJ, et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 2010; 362:2271-81.
10. Kumwenda NI, Hoover DR, Mofenson LM, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 2008; 359:119-29.
11. Clarke MJ, Stewart LA. Systematic reviews: obtaining data from randomised controlled trials: how much do we need for reliable and informative meta-analyses? BMJ 1994; 309:1007-10.
12. Whitehead A. Meta-analysis of controlled clinical trials. Oxford, UK: John Wiley and Sons, 2002.
13. Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ 2010; 340:c221.
14. Coovadia HM, Brown ER, Fowler MG, et al. for the HPTN 046 Protocol Team. Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial. Lancet 2012; 379:221-28.
15. Chavula C, Long D, Kayira D, et al. Stopping the control arm in response to the DSMB: mother's choice of HIV prophylaxis during breastfeeding in the BAN study. Contemp Clin Trials 2012; 33:55-59.
16. World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infections in infants: recommendations for a public health approach-2010 version. Geneva, Switzerland: WHO, 2010. Available at: http://whqlibdoc.who.int/publications/2010/9789241599818-eng.pdf. Accessed 14 February 2012.
17. Schouten EJ, Jahn A, Midiani D, et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet 2011; 378:282-4.
18. Kesho Bora Study Group. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. Lancet Infect Dis 2011; 11:171-80.
19. Shapiro RL, Hughes MD, Ogwu A, et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med. 2010; 362:2282-94.
20. Cohen MS, Chen YQ, McCauleyM, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011; 365:493-505.
21. Chibwesha CJ, Giganti MJ, Putta N, et al. Optimal time on HAART for prevention of mother-to-child transmission of HIV. J Acquir Immune Defic Syndr 2011; 58:224-8.
22. World Health Organization. The treatment 2.0 framework for action: catalysing the next phase of treatment, care and support. Geneva, Switzerland: WHO, 2011. Available at: http://whqlibdoc.who.int/publications/2011/ 9789241501934-eng.pdf. Accessed 27 September 2012.